| P2093 | author name string | Ai Kotani | |
| | Ryo Koyama-Nasu | |
| | Ryutaro Kotaki | |
| | Natsuko Yamakawa | |
| P2860 | cites work | Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent | Q24317920 |
| | Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 |
| | A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 |
| | Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 |
| | The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 | Q24608778 |
| | miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221 | Q24643476 |
| | Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters | Q24645192 |
| | Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma | Q24648226 |
| | Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes | Q24651802 |
| | The establishment of B versus T cell identity | Q27025844 |
| | RAS is regulated by the let-7 microRNA family | Q27860522 |
| | The functions of animal microRNAs | Q27860621 |
| | MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 |
| | A microRNA polycistron as a potential human oncogene | Q27860720 |
| | Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 |
| | Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 |
| | The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 | Q27861068 |
| | MicroRNA expression profiles classify human cancers | Q28032481 |
| | MicroRNA-directed cleavage of HOXB8 mRNA | Q28131834 |
| | High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma | Q28236173 |
| | miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1 | Q28239225 |
| | New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors | Q28254539 |
| | Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 |
| | Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation | Q28268899 |
| | Treatment of HCV infection by targeting microRNA | Q29547712 |
| | Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 |
| | Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice | Q29619279 |
| | MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb | Q29619411 |
| | BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas | Q29622911 |
| | microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4. | Q31039862 |
| | MicroRNA 125b inhibition of B cell differentiation in germinal centers | Q33941947 |
| | A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate | Q33961160 |
| | MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. | Q34024981 |
| | OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. | Q34130311 |
| | miRNAs and cancer: an epigenetics view | Q34286618 |
| | miR-34 - a microRNA replacement therapy is headed to the clinic | Q34640230 |
| | miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression | Q34762601 |
| | Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer | Q35044404 |
| | Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer | Q35052004 |
| | Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma | Q35080097 |
| | MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. | Q35201318 |
| | Identification of Flt3⁺CD150⁻ myeloid progenitors in adult mouse bone marrow that harbor T lymphoid developmental potential | Q35212348 |
| | miR-155 regulates HGAL expression and increases lymphoma cell motility | Q35669239 |
| | Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A. | Q35837230 |
| | A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway | Q35941053 |
| | MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma | Q36020910 |
| | DNA damage induces NF-κB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion | Q36052395 |
| | The microRNA-212/132 cluster regulates B cell development by targeting Sox4. | Q36080716 |
| | Profile of Exosomal and Intracellular microRNA in Gamma-Herpesvirus-Infected Lymphoma Cell Lines | Q36128494 |
| | miR-21 expression predicts prognosis in diffuse large B-cell lymphoma | Q36464776 |
| | microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival | Q37027816 |
| | Patterns of microRNA expression characterize stages of human B-cell differentiation. | Q37187523 |
| | Hypoxia response and microRNAs: no longer two separate worlds. | Q37215302 |
| | A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. | Q37229105 |
| | Regulation of B-cell differentiation by microRNAs and RNA-binding proteins. | Q37330371 |
| | Cell to cell signalling via exosomes through esRNA | Q37406712 |
| | The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients | Q37594546 |
| | Transcription control of early B cell differentiation | Q37690003 |
| | Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 | Q37706993 |
| | A map for lineage restriction of progenitors during hematopoiesis: the essence of the myeloid‐based model | Q37802416 |
| | Transcriptional control of early T and B cell developmental choices | Q38182644 |
| | Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma | Q38316590 |
| | Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies | Q38811147 |
| | Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro | Q39177128 |
| | MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen | Q39218802 |
| | Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2. | Q39344864 |
| | Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1 | Q39565441 |
| | MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. | Q39637718 |
| | miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes | Q39863600 |
| | MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma | Q40135314 |
| | Knockdown of LMP1-induced miR-155 sensitizes nasopharyngeal carcinoma cells to radiotherapy in vitro | Q40500515 |
| | The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential | Q42140288 |
| | Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells | Q42143359 |
| | Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation | Q42705645 |
| | MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia | Q42724150 |
| | Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage | Q42808536 |
| | Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors | Q42833178 |
| | Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior | Q45210930 |
| | Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. | Q46455047 |
| | miR-155 regulates high glucose-induced cardiac fibrosis via the TGF-β signaling pathway | Q48177139 |
| | Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients. | Q48277809 |
| | High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders | Q48987219 |
| | Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. | Q50876705 |
| | T cell progenitors emerge earlier than B cell progenitors in the murine fetal liver. | Q51081086 |
| | Emergence of T cell progenitors without B cell or myeloid differentiation potential at the earliest stage of hematopoiesis in the murine fetal liver. | Q51091527 |
| | Direct evidence for the commitment of hematopoietic stem cells to T, B and myeloid lineages in murine fetal liver. | Q51102224 |
| | Anti-inflammatory effects of curcumin are associated with down regulating microRNA-155 in LPS-treated macrophages and mice. | Q52783726 |
| | B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells. | Q53271931 |
| | miR-155/BIC as an oncogenic microRNA. | Q55041350 |
| | TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo | Q73168724 |
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| | hemopoiesis | Q919283 |
| P577 | publication date | 2017-07-11 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | miRNAs in Normal and Malignant Hematopoiesis | |
| P478 | volume | 18 | |